Cargando…
Heat‐labile Escherichia coli toxin enhances the induction of allergen‐specific IgG antibodies in epicutaneous patch vaccination
Epicutaneous allergen‐specific immunotherapy (EPIT) is proposed as an alternative route for allergen‐specific immunotherapy (AIT). The induction of allergen‐specific blocking IgG antibodies represents an important mechanism underlying AIT, but has not been investigated for EPIT. Here, we compared th...
Autores principales: | Cabauatan, C. R., Campana, R., Niespodziana, K., Reinisch, C., Lundberg, U., Meinke, A., Henning, R., Neubauer, A., Valenta, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215485/ https://www.ncbi.nlm.nih.gov/pubmed/27568860 http://dx.doi.org/10.1111/all.13036 |
Ejemplares similares
-
Induction of allergen-specific blocking IgG using patch delivered recombinant Bet v 1 in guinea pigs
por: Cabauatan, Clarissa, et al.
Publicado: (2014) -
Epicutaneous allergen application preferentially boosts specific T cell responses in sensitized patients
por: Campana, Raffaela, et al.
Publicado: (2017) -
The role of allergen‐specific IgE, IgG and IgA in allergic disease
por: Shamji, Mohamed H., et al.
Publicado: (2021) -
Innovative Systems to Deliver Allergen Powder for Epicutaneous Immunotherapy
por: Wang, Yensheng, et al.
Publicado: (2021) -
Dissociation of the respiratory syncytial virus F protein-specific human IgG, IgA and IgM response
por: Borochova, Kristina, et al.
Publicado: (2021)